LON:CIZ

Cizzle Biotechnology (CIZ) Share Forecast, Price & News

GBX 1.80

0.00 (0.00%)

(As of 05/27/2022 12:00 AM ET)

Add

Compare

Today's Range: 1.76
▼
1.84
50-Day Range: 1.79
▼
2.49
52-Week Range: 1.70
▼
7.50

Volume: 605,736 shs
Average Volume: 7.36 million shs
Market Capitalization: £5.01 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive CIZ News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein gene and its potential as a diagnostic biomarker for detection and management of lung cancer. The company's CIZ1 promotes DNA replication and its organization and control. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:CIZ
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.cizzlebiotechnology.com
Phone: N/A
Fax: N/A
Employees: 2
Year Founded: N/A

Sales & Book Value

Annual Sales: £25 thousand
Price / Sales: 200.48
Cash Flow: GBX 1.62 per share
Price / Cash Flow: 1.11
Book Value: GBX 1.50 per share
Price / Book: 1.20

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.16
Quick Ratio: 1.10

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 278,448,000
Free Float: N/A
Market Cap: £5.01 million
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cizzle Biotechnology.

0.0 Community Rank

Outperform Votes
Cizzle Biotechnology has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cizzle Biotechnology has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Cizzle Biotechnology and other stocks. Vote “Outperform” if you believe CIZ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CIZ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cizzle Biotechnology does not currently pay a dividend.
Dividend Growth
Cizzle Biotechnology does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cizzle Biotechnology insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cizzle Biotechnology is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cizzle Biotechnology is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cizzle Biotechnology has a P/B Ratio of 1.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Cizzle Biotechnology (LON:CIZ) Frequently Asked Questions

Who are Cizzle Biotechnology's key executives?: Cizzle Biotechnology's management team includes the following people:
Mr. Allan John Syms, Exec. Chairman (Age 64)
Dr. Dawn Coverley, Founder, Chief Scientific Officer & Non-Exec. Director (Age 55)
Mr. Nigel R. Lee, Fin. Director & Director (Age 59)
Mr. Morgan Williams, Head of Commercialisation for Yorkshire Cancer Research and Board Observer
Who are some of Cizzle Biotechnology's key competitors?: Some companies that are related to Cizzle Biotechnology include AorTech International (AOR), Hemostemix (HEM), NetScientific (NSCI), Oxford BioDynamics (OBD), Ensysce Biosciences (ENSC), IXICO (IXI), Bioasis Technologies (BTI), ImmuPharma (IMM), ValiRx (VAL), Quest PharmaTech (QPT), Hemogenyx Pharmaceuticals (HEMO), Crescita Therapeutics (CTX), Fusion Antibodies (FAB), Hvivo (HVO) and Realm Therapeutics (RLM).
View all of CIZ's competitors.
What is Cizzle Biotechnology's stock symbol?: Cizzle Biotechnology trades on the London Stock Exchange (LON) under the ticker symbol "CIZ."
How do I buy shares of Cizzle Biotechnology?: Shares of CIZ and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Cizzle Biotechnology's stock price today?: One share of CIZ stock can currently be purchased for approximately GBX 1.80.
How much money does Cizzle Biotechnology make?: Cizzle Biotechnology has a market capitalization of £5.01 million and generates £25 thousand in revenue each year.
How many employees does Cizzle Biotechnology have?: Cizzle Biotechnology employs 2 workers across the globe.
What is Cizzle Biotechnology's official website?: The official website for Cizzle Biotechnology is www.cizzlebiotechnology.com.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.